| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 40,400 | $1 | $161.6K |
| J3262 | Injection, tocilizumab, 1 mg | 38,680 | $1 | $154.7K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 5,460 | $30 | $142K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 4,180 | $30 | $141.9K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 11,200 | $10 | $112K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 490 | $90 | $42.3K |
| J0897 | Injection, denosumab, 1 mg | 1,680 | $20 | $30.2K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 290 | $100 | $27.6K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 230 | $50 | $12.2K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 50 | $150 | $7.5K |